Chromatographic resolution, chiroptical characterization and preliminary pharmacological evaluation of the enantiomers of butibufen: a comparison with ibuprofen

Enantiomeric resolution of butibufen has been achieved on a cellulose tris( 3,5-dimethylphenylcarbamate) chiral stationary phase with hexane-isopropano l-trifluoroacetic acid, 100 : 1.2 : 0.02 (v/v/v) as mobile phase at a flow rate of 1.0 mL min(-1). Semi-preparative isolation of the enantiomers then chiroptical characteriza tion indicated that the order of elution was (-)-R- before (+)-S-butibufen. When tested for their effects on the cyclooxygenase and 5-lipoxygenase pat hways of eicosanoid metabolism in calcium ionophore-activated rat peritonea l leukocytes it was found that (+)-S-butibufen inhibited generation of thro mboxane B-2 (TXB2) and prostaglandin E-2 (PGE(2)) (cyclooxygenase pathway), with an IC50 of 1.5 mu M (approx.), whereas the (-)-R enantiomer was essen tially inactive. Neither enantiomer inhibited the 5-lipoxygenase pathway. I n this regard, (+)-S-butibufen was approximately five times less potent as a cyclooxygenase inhibitor than (+)-S-ibuprofen. These results show the enantiomeric specificity and pathway selectivity of this novel non-steroidal anti-inflammatory drug.